Tailoring Treatment With Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel: Difference between revisions
(New page: {{SI}} <font color="blue">How to edit trial information:</font> <small> Log in, click on the word [<font color="blue">edit</font>] to the right of the section you wo...) |
No edit summary |
||
| Line 1: | Line 1: | ||
{{SI}} | {{SI}} | ||
__NOTOC__ | |||
<font color="blue">How to edit trial information:</font> <small> [[Special:UserLogin|Log in]], click on the word [<font color="blue">edit</font>] to the right of the section you would like to edit, type in the appropriate information, click save page at the bottom when you are done. The template is the minimum elements required by the World Health Organization. You can add additional sections.</small> [[Help:How to add a trial to the clinical trial wiki|More help to add a trial here.]] | <font color="blue">How to edit trial information:</font> <small> [[Special:UserLogin|Log in]], click on the word [<font color="blue">edit</font>] to the right of the section you would like to edit, type in the appropriate information, click save page at the bottom when you are done. The template is the minimum elements required by the World Health Organization. You can add additional sections.</small> [[Help:How to add a trial to the clinical trial wiki|More help to add a trial here.]] | ||
Revision as of 20:16, 2 June 2009
|
WikiDoc Resources for Tailoring Treatment With Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel |
|
Articles |
|---|
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
|
|
Guidelines / Policies / Govt |
|
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
|
|
Healthcare Provider Resources |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
How to edit trial information: Log in, click on the word [edit] to the right of the section you would like to edit, type in the appropriate information, click save page at the bottom when you are done. The template is the minimum elements required by the World Health Organization. You can add additional sections. More help to add a trial here.
Complete Title of Study
Tailoring Treatment With Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel
Study Acronym (The trial's abbreviation if there is one)
3T/2R
Principal Investigator, Co-investigators, and Collaborating Institutions
Principal investigator: Marco Valgimigli, MD, PhD
Institution: Universitaria di Ferrara, Ferrara, Fe, Italy
Overview of Trial
The goal of the study was to evaluate whether adding tirofiban, administered at high bolus dose on top of aspirin and clopidogrel will lead to a lower rate of periprocedural myocardial infarction after percutaneous coronary intervention in elective patients presenting with aspirin and/or clopidogrel resistance.
Disease State(s) Studied (e.g. acute MI, breast cancer, etc.)
Patients older than 18 years scheduled for coronary angiography and/or PCI with stable or unstable troponin and CK-MB negative coronary artery disease showing aspirin and or clopidogrel resistance (ACR.)
Study Phase (e.g. Phase I,II,III,IV) Study Phases are defined here
Phase IV
Study Design (e.g. multicenter, randomized, double blind, placebo controlled)
Randomized, Double Blind (Subject, Investigator, Outcomes Assessor), Placebo Control, Treatment, Parallel Assignment, Efficacy Study
Study Arms and How They Were Treated (Intervention) (Explanation here)
Patients were randomized to